Pfizer’s biosimilar Zirabev wins EU approval
Pfizer has announced European approval of its Avastin biosimilar Zirabev.
Read More
Tag: Zirabev
Seven medicines leap closer to EU approval
The European Medicines Agency’s human medicines committee (CHMP) has put forward seven medicines for approval in the region.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
